NEW YORK (GenomeWeb) – Thermo Fisher Scientific reported before the opening of the market on Thursday that its second quarter revenues increased 6 percent, thanks in part to large increases in laboratory products and services revenues and life sciences solutions revenues.

Separately today, Thermo Fisher said that it has signed a deal with Health BioMed to support that company's efforts to develop molecular diagnostic kits for infectious disease and pharmacogenomics screening for the Chinese market.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.